These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6255785

  • 1. Studies with aprindine.
    Zipes DP, Elharrar V, Gilmour RF, Heger JJ, Prystowsky EN.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1055-62. PubMed ID: 6255785
    [Abstract] [Full Text] [Related]

  • 2. Aprindine for treatment of ventricular arrhythmias in the dog.
    Muir WW, Bonagura JD.
    Am J Vet Res; 1982 Oct; 43(10):1815-9. PubMed ID: 7149383
    [Abstract] [Full Text] [Related]

  • 3. Aprindine therapy for refractory ventricular tachycardia.
    Khan AH, Carleton RA, Chown M.
    Arch Intern Med; 1983 Feb; 143(2):229-32. PubMed ID: 6824389
    [Abstract] [Full Text] [Related]

  • 4. Treatment of recurrent ventricular tachycardia and fibrillation with aprindine.
    Fasola AF, Noble RJ, Zipes DP.
    Am J Cardiol; 1977 May 26; 39(6):903-9. PubMed ID: 67800
    [Abstract] [Full Text] [Related]

  • 5. Aprindine.
    Danilo P.
    Am Heart J; 1979 Jan 26; 97(1):119-24. PubMed ID: 364967
    [Abstract] [Full Text] [Related]

  • 6. Aprindine: a review.
    Stoel I, Hagemeijer F.
    Eur Heart J; 1980 Apr 26; 1(2):147-56. PubMed ID: 7026249
    [No Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic and antifibrillatory properties of aprindine.
    Kroll DA, Lucchesi BR.
    J Pharmacol Exp Ther; 1975 Aug 26; 194(2):427-34. PubMed ID: 1151768
    [Abstract] [Full Text] [Related]

  • 8. [Anti-arrhythmic effects of injectable aprindine in the dog].
    Cheymol G, Gilbert JC, Mouillé P.
    Therapie; 1974 Aug 26; 29(5):719-30. PubMed ID: 4549334
    [No Abstract] [Full Text] [Related]

  • 9. [Aprindine, an anti-arrhythmia agent for arrhythmia associated with myocardial infarct].
    Ikeda T, Kubota K, Higashino A, Hattori N.
    Nihon Rinsho; 1983 Dec 26; 41(12):2760-5. PubMed ID: 6674561
    [No Abstract] [Full Text] [Related]

  • 10. Prolongation of cardiac conduction times by intravenous aprindine in man.
    Greene HL, Reid PR, Schaeffer AH.
    Am J Cardiol; 1978 Dec 26; 42(6):1002-6. PubMed ID: 727127
    [Abstract] [Full Text] [Related]

  • 11. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects.
    Tsutsui H, Araki H, Nagata Y, Nakamura M.
    Clin Ther; 1984 Dec 26; 6(6):770-7. PubMed ID: 6509460
    [Abstract] [Full Text] [Related]

  • 12. Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog.
    Nattel S, Pedersen DH, Zipes DP.
    Cardiovasc Res; 1981 Feb 26; 15(2):80-5. PubMed ID: 7260980
    [Abstract] [Full Text] [Related]

  • 13. Effect of aprindine on transmembrane currents and contractile force in frog atria.
    Gilmour RF, Chikharev VN, Jurevichus JA, Zacharov SI, Zipes DP, Rosenshtraukh LV.
    J Pharmacol Exp Ther; 1981 May 26; 217(2):390-6. PubMed ID: 7229981
    [Abstract] [Full Text] [Related]

  • 14. Agranulocytosis associated with aprindine therapy.
    Bodenheimer HC, Samarel AM.
    Arch Intern Med; 1979 Oct 26; 139(10):1181-2. PubMed ID: 485754
    [Abstract] [Full Text] [Related]

  • 15. [Fatal course of agranulocytosis during antiarryhthmic aprindine therapy].
    Hausamen TU, Weber FW.
    Dtsch Med Wochenschr; 1977 Oct 21; 102(42):1523-4. PubMed ID: 913289
    [No Abstract] [Full Text] [Related]

  • 16. Torsade des pointes and aprindine.
    Sideris DA, Kontoyannis DA, Moulopoulos SD.
    Int J Cardiol; 1985 Apr 21; 7(4):413-6. PubMed ID: 2580805
    [Abstract] [Full Text] [Related]

  • 17. Agranulocytosis and aprindine.
    van Leeuwen R, Meyboom RH.
    Lancet; 1976 Nov 20; 2(7995):1137. PubMed ID: 62971
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of clinical efficacy and plasma levels of aprindine.
    Malini PL, Ambrosioni E, Bracchetti D, Magnani B.
    Int J Clin Pharmacol Biopharm; 1979 Oct 20; 17(10):396-403. PubMed ID: 500254
    [Abstract] [Full Text] [Related]

  • 19. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR, Greene HL, Varghese PJ.
    Br Heart J; 1977 Dec 20; 39(12):1353-60. PubMed ID: 603737
    [Abstract] [Full Text] [Related]

  • 20. Effective plasma concentrations of aprindine in canine ventricular arrhythmias.
    Hashimoto K, Komori S, Ishii M, Kamiya J.
    J Cardiovasc Pharmacol; 1984 Dec 20; 6(1):12-9. PubMed ID: 6199593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.